2. Anti-infection GPCR/G Protein
  3. Bacterial Free Fatty Acid Receptor
  4. AMG 837 sodium salt

AMG 837 sodium salt is an orally active, selective GPR40/FFA1 agonist with an EC50 of 1.5 nM against human GPR40. AMG 837 sodium salt stimulates insulin secretion in a glucose-dependent manner, and effectively improves glycemic control in both normal and diabetic rodent models. AMG 837 sodium salt binds to the BacA protein and impairs the survival and replication of Brucella. AMG 837 sodium salt can be used in research related to type 2 diabetes and brucellosis.

For research use only. We do not sell to patients.

CAS No. : 865231-45-4

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of AMG 837 sodium salt:

Other Forms of AMG 837 sodium salt:

AMG 837 sodium salt Related Antibodies

Top Publications Citing Use of Products

    AMG 837 sodium salt purchased from MedChemExpress. Usage Cited in: Biochem Biophys Res Commun. 2025 Apr 9:757:151624.  [Abstract]

    Ability of different concentrations compounds or drugs (GM, Gentamicin, Sterile; AMG 837; RORγt 13; RIF; 4, 16 μg/mL) to clear B. melitensis TZ in RAW264.7 cells at 24 h. Cells appear blue; B. melitensis TZ appear green.

    View All Free Fatty Acid Receptor Isoform Specific Products:

    View All Isoforms
    FFAR1 FFAR2 FFAR3 FFAR4

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    AMG 837 sodium salt is an orally active, selective GPR40/FFA1 agonist with an EC50 of 1.5 nM against human GPR40. AMG 837 sodium salt stimulates insulin secretion in a glucose-dependent manner, and effectively improves glycemic control in both normal and diabetic rodent models. AMG 837 sodium salt binds to the BacA protein and impairs the survival and replication of Brucella. AMG 837 sodium salt can be used in research related to type 2 diabetes and brucellosis[1][2].

    In Vitro

    AMG 837 sodium salt stimulates inositol phosphate accumulation in A9_GPR40 cells with an EC50 of 7.8 nM[1].
    AMG 837 sodium salt potently and selectively stimulates Ca2+ influx mediated by human GPR40 in CHO cells, with an EC50 of 13.5 nM, and shows no activity against the homologous human GPR41, GPR43 or GPR120 receptors[1].
    AMG 837 sodium salt activates GPR40 across multiple preclinical species, with EC50 values of 22.6 nM in mice, 31.7 nM in rats, 71.3 nM in dogs, and 30.6 nM in rhesus monkeys in the CHO cell aequorin assay[1].
    The potency of AMG 837 sodium salt against human GPR40 decreases in the presence of serum albumin or human serum, with an EC50 value of 210 nM in 0.625% HSA and 2140 nM in 100% human serum[1].
    AMG 837 (1 μM) sodium salt enhances insulin secretion activity of primary mouse islets in a glucose-dependent manner[1].
    AMG 837 sodium salt inhibits the growth of B. melitensis TZ, B. melitensis M5-90, B. suis S2, and B. abortus A19[2].
    AMG 837 (4-16 μg/mL; 6-48 h) sodium salt effectively inhibits B. melitensis TZ in RAW264.7 cells at a concentration of 4 μg/mL, and completely eliminates the bacterium at 16 μg/mL following 6, 12, 24, and 48 h of incubation[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    AMG 837 sodium salt Related Antibodies
    In Vivo

    AMG 837 (0.03-0.3 mg/kg; p.o.; single administration) sodium salt improves glucose tolerance in a dose-dependent manner in normal Sprague-Dawley rats[1].
    AMG 837 (0.3 mg/kg; p.o.; single administration) sodium salt effectively improves glucose tolerance and increases glucose-stimulated insulin secretion in normal Sprague-Dawley rats even after two consecutive glucose challenges[1].
    AMG 837 (0.3-3 mg/kg; p.o.; single administration) sodium salt reduces the postprandial blood glucose AUC0-t by approximately 46% in insulin-resistant Zucker obese rats by enhancing glucose-stimulated insulin secretion[1].
    AMG 837 (0.03-0.3 mg/kg; p.o.; once daily for 21 days) sodium salt maintains the efficacy of improving glucose tolerance in insulin-resistant Zucker obese rats, and reduces glucose AUC0-t by 25% at the dose of 0.3 mg/kg on day 21 of administration; its mechanism of action is to continuously stimulate insulin secretion via glucose, without affecting the body weight of rats[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Sprague-Dawley (8-week-old male)[1]
    Dosage: 0.03 mg/kg; 0.1 mg/kg; 0.3 mg/kg
    Administration: p.o.; single dose
    Result: Did not affect baseline glucose levels 30 minutes post-dose.
    Induced a dose-dependent increase in plasma insulin levels, with peak secretion at 5 and 15 minutes post-glucose challenge.
    Achieved a half-maximal dose to lower post-prandial glucose of approximately 0.05 mg/kg.
    Animal Model: Sprague-Dawley (8-week-old male)[1]
    Dosage: 0.3 mg/kg
    Administration: p.o.; single dose
    Result: Improved blood glucose levels during both glucose challenges, with reduced glucose AUC during each challenge.
    Induced peak insulin secretion soon after each glucose administration, mirroring the single-challenge response.
    Animal Model: Zucker fatty (fa/fa) (8-week-old male; insulin-resistant, impaired glucose tolerance model)[1]
    Dosage: 0.3 mg/kg; 1 mg/kg; 3 mg/kg
    Administration: p.o.; single dose
    Result: Caused baseline glucose levels to trend lower and insulin levels to trend higher 30 minutes post-dose, though neither reached statistical significance.
    Reduced post-glucose challenge glucose levels at all doses, with glucose AUC reduced by ~46% for all doses.
    Induced a spike in plasma insulin levels 5 and 15 minutes post-glucose challenge at all doses.
    Animal Model: Zucker fatty (fa/fa) (8-week-old male; insulin-resistant, impaired glucose tolerance model)[1]
    Dosage: 0.3 mg/kg; 1 mg/kg; 3 mg/kg
    Administration: p.o.; daily; 21 days
    Result: On day 1, reduced glucose AUC by 17%, 34% , and 39% at 0.03, 0.1, and 0.3 mg/kg doses, respectively, with corresponding increased insulin secretion post-glucose challenge.
    On day 21, reduced glucose AUC by 7%, 15%, and 25% at 0.03, 0.1, and 0.3 mg/kg doses, respectively, with increased insulin secretion in the mid- and high-dose groups post-glucose challenge.
    Caused no differences in body weight between treatment and control groups over the 21-day period.
    Molecular Weight

    460.42

    Formula

    C26H20F3NaO3
    CAS No.
    SMILES

    O=C(O[Na])C[C@H](C#CC)C1=CC=C(C=C1)OCC2=CC=CC(C3=CC=C(C(F)(F)F)C=C3)=C2
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage

    Please store the product under the recommended conditions in the Certificate of Analysis.
    Purity & Documentation
    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    AMG 837 sodium salt Related Classifications

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Keywords:

    AMG 837865231-45-4AMG837AMG-837BacterialFree Fatty Acid ReceptorFFARInhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Requested Quantity *

    Applicant Name *

    		 

    Salutation

    Email Address *

    		 

    Phone Number *

    Department

    		 

    Organization Name *

    City

    State

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    AMG 837 sodium salt
    Cat. No.:
    HY-13967A
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    SAFETY DATA SHEET (SDS)

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.